Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OrganoTSE:6368 +3.03%93 Debt-to-Equity is 0.26 as of Jun. 2026, which is 4% above its 10-year median of 0.25. GuruFocus rates TSE:6368 with a GF Score™ of 93/100 and a GF Value™ of 円9,577.69 (Modestly Overvalued). Among 2,692 Industrial Products companies, Organo ranks better than 55.87% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Organo's Debt-to-Equity or its related term are showing as below:
TSE:6368'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.16 Med: 0.25 Max: 0.38
Current: 0.24
During the past 13 years, the highest Debt-to-Equity Ratio of Organo was 0.38. The lowest was 0.16. And the median was 0.25.
TSE:6368's Debt-to-Equity is ranked better than 55.87% of 2692
companies
in the Industrial Products industry
Industry Median: 0.29
vs TSE:6368: 0.24
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Organo Debt-to-Equity Related Terms
Organo Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Organo's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6368 vs VLTO, ZWS, CECO: Debt-to-Equity Comparison
For the Pollution & Treatment Controls subindustry, Organo's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organo Debt-to-Equity vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Organo's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Organo's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organo (TSE:6368) has a Debt-to-Equity of 0.26 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Organo and its competitors. This is near median its historical median of 0.25. Over the past decade, Organo's Debt-to-Equity has ranged from 0.16 to 0.38. According to the industry distribution chart, Organo ranks #1188 out of 2692 companies in the Industrial Products industry, placing it in the top 44.1%.
Is Organo's Debt-to-Equity too high?
Organo's current Debt-to-Equity of 0.26 is near median its 10-year median of 0.25. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.38. The Industrial Products industry median Debt-to-Equity is 0.29. Organo's value of 0.26 is 10.3% below this industry median. Based on the distribution chart, Organo ranks #1188 out of 2692 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Organo has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Organo's Debt-to-Equity compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Organo ranks #1188 out of 2692 companies for Debt-to-Equity. This puts Organo in the upper half of its industry. The industry median Debt-to-Equity is 0.29. Organo's value of 0.26 is 10.3% below this benchmark. Historically, Organo's own Debt-to-Equity has ranged from 0.16 to 0.38 over the past decade. While the company's 10-year median is 0.25 vs. the industry median of 0.29, Organo has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Industrial Products company?
The median Debt-to-Equity among Industrial Products companies is 0.29, based on 2,692 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Organo's current Debt-to-Equity of 0.26 is 10.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Organo and its competitors. For the Industrial Products industry, the median Debt-to-Equity is 0.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organo's current Debt-to-Equity is 0.26, which is near median its own 10-year median of 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organo stock overvalued right now?
Based on GuruFocus' analysis, Organo (TSE:6368) is currently considered Modestly Overvalued. The stock's GF Value™ is 円9,577.69, compared to a current price of 円12,395.00 — trading 29.4% above its estimated fair value. The current Debt-to-Equity is 0.26, which is near median its 10-year median of 0.25 and 10.3% below the Industrial Products industry median of 0.29. Organo's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Organo (TSE:6368), the current Debt-to-Equity is 0.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organo (TSE:6368) Overvalued in 2026?
Based on GuruFocus' analysis, Organo stock appears to be overvalued.
The current stock price of 円12,395.00 is trading 29.4% above its estimated GF Value™ of 円9,577.69.
GuruFocus considers Organo to be Modestly Overvalued.
Key valuation signals for TSE:6368:
Debt-to-Equity: 0.26 (near median its 10-year median of 0.25)
GF Value™: 円9,577.69 vs. price of 円12,395.00 (29.4% above fair value)
Industry Position: 10.3% below the Industrial Products median (#1188 of 2692)
No single metric tells the full story. See the TSE:6368 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.
93GF Score
Get the complete analysis for TSE:6368
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6368 has been successfully added to your 
